ZA200205164B - A complex comprising OCIF and polysaccaride. - Google Patents

A complex comprising OCIF and polysaccaride.

Info

Publication number
ZA200205164B
ZA200205164B ZA200205164A ZA200205164A ZA200205164B ZA 200205164 B ZA200205164 B ZA 200205164B ZA 200205164 A ZA200205164 A ZA 200205164A ZA 200205164 A ZA200205164 A ZA 200205164A ZA 200205164 B ZA200205164 B ZA 200205164B
Authority
ZA
South Africa
Prior art keywords
polysaccaride
ocif
complex
Prior art date
Application number
ZA200205164A
Other languages
English (en)
Inventor
Yamamoto Shinichi
Kurihara Atsushi
Kondo Junichi
Mochizuki Shinichi
Miyazaki Hideki
Okada Junichi
Numazawa Taku
Tsuda Eisuke
Nishi Hirotaka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ZA200205164B publication Critical patent/ZA200205164B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200205164A 2001-06-29 2002-06-27 A complex comprising OCIF and polysaccaride. ZA200205164B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001198985 2001-06-29

Publications (1)

Publication Number Publication Date
ZA200205164B true ZA200205164B (en) 2003-03-24

Family

ID=19036337

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205164A ZA200205164B (en) 2001-06-29 2002-06-27 A complex comprising OCIF and polysaccaride.

Country Status (22)

Country Link
US (3) US20030045456A1 (xx)
EP (1) EP1270015A3 (xx)
KR (1) KR20030003124A (xx)
CN (1) CN1442201A (xx)
AR (1) AR034716A1 (xx)
AU (1) AU783126B2 (xx)
BR (1) BR0202439A (xx)
CA (1) CA2392383A1 (xx)
CO (1) CO5390084A1 (xx)
CZ (1) CZ20022231A3 (xx)
HK (1) HK1048762A1 (xx)
HU (1) HUP0202119A2 (xx)
IL (1) IL150448A0 (xx)
MX (1) MXPA02006511A (xx)
NO (1) NO20023144L (xx)
PA (1) PA8549401A1 (xx)
PE (1) PE20030254A1 (xx)
PL (1) PL354799A1 (xx)
RU (1) RU2232594C2 (xx)
SG (1) SG98059A1 (xx)
SK (1) SK9492002A3 (xx)
ZA (1) ZA200205164B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
RU2223782C2 (ru) 1998-10-28 2004-02-20 Санкио Компани, Лимитед Средство для лечения патологического костного метаболизма
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
PA8568001A1 (es) * 2002-03-01 2003-11-12 Sankyo Co Composicion farmaceutica
US7585840B2 (en) * 2002-04-10 2009-09-08 Merck Serono S.A. Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
JP4430403B2 (ja) 2002-04-10 2010-03-10 メルク セローノ ソシエテ アノニム 線維化疾患の治療および／または予防のためのオステオプロテゲリンの使用
TW200400830A (en) * 2002-06-07 2004-01-16 Sankyo Co A pharmaceutical composition used in the treatment of bone erosion
KR100840830B1 (ko) * 2006-09-03 2008-06-23 재단법인서울대학교산학협력재단 고분자 히알루론산을 포함하는 골흡수 저해용 조성물
ITMI20121316A1 (it) * 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
CN115594776B (zh) * 2022-09-19 2024-03-15 山东大学 一种ROS响应性聚合物Mal-PHB-Dextran及细胞背包载药系统

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207A (en) * 1845-09-27 lewis
US216297A (en) * 1879-06-10 Improvement in ironing-stands
US139325A (en) * 1873-05-27 Improvement in carriage-springs
US45456A (en) * 1864-12-13 Improved apparatus for carbureting air
US181418A (en) * 1876-08-22 Improvement in gas apparatus
US31725A (en) * 1861-03-19 Improvement in cultivators
TW318142B (xx) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US20030207827A1 (en) * 1995-12-22 2003-11-06 William J. Boyle Osteoprotegerin
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
US6613544B1 (en) * 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6656508B2 (en) * 1997-04-17 2003-12-02 Amgen Inc. Sustained-release alginate gels
HUP0002062A3 (en) * 1997-09-24 2002-09-30 Sankyo Co Method for diagnosing bone dysbolism
AU4061899A (en) * 1998-06-15 2000-01-05 Takeda Chemical Industries Ltd. Thienodipyridine derivatives, production and use thereof
RU2223782C2 (ru) * 1998-10-28 2004-02-20 Санкио Компани, Лимитед Средство для лечения патологического костного метаболизма
EP1140136B1 (en) * 1999-09-03 2007-05-16 Amgen Inc. Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU2001295850A1 (en) * 2000-09-28 2002-04-08 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
EP1270015A3 (en) * 2001-06-29 2004-02-25 Sankyo Company Limited A complex comprising OCIF and Polysaccharide
PA8568001A1 (es) * 2002-03-01 2003-11-12 Sankyo Co Composicion farmaceutica

Also Published As

Publication number Publication date
RU2232594C2 (ru) 2004-07-20
RU2002117385A (ru) 2004-01-27
US20030139325A1 (en) 2003-07-24
CA2392383A1 (en) 2002-12-29
HK1048762A1 (zh) 2003-04-17
EP1270015A2 (en) 2003-01-02
EP1270015A3 (en) 2004-02-25
AU5071902A (en) 2003-01-02
PE20030254A1 (es) 2003-03-19
IL150448A0 (en) 2002-12-01
CN1442201A (zh) 2003-09-17
SK9492002A3 (en) 2003-02-04
PL354799A1 (en) 2002-12-30
AU783126B2 (en) 2005-09-29
HUP0202119A2 (hu) 2003-04-28
PA8549401A1 (es) 2003-07-28
MXPA02006511A (es) 2004-08-11
NO20023144D0 (no) 2002-06-28
US20030045456A1 (en) 2003-03-06
SG98059A1 (en) 2003-08-20
CZ20022231A3 (cs) 2003-02-12
HU0202119D0 (xx) 2002-08-28
KR20030003124A (ko) 2003-01-09
AR034716A1 (es) 2004-03-17
NO20023144L (no) 2002-12-30
BR0202439A (pt) 2003-06-10
US20060084595A1 (en) 2006-04-20
CO5390084A1 (es) 2004-04-30

Similar Documents

Publication Publication Date Title
MXPA03006788A (es) Tabletas y polvos solubles en agua.
GB0316651D0 (en) A universasl software application
MXPA03004885A (es) Base de conexion.
MXPA01009037A (es) I-bet.
ZA200205164B (en) A complex comprising OCIF and polysaccaride.
AU148688S (en) A spoon
SG104269A1 (en) Barge
ZA200203813B (en) A tomb.
GB0109417D0 (en) A.r.s.i.d.s.
GB0104102D0 (en) Wheelchair up and down W.U.A.D
GB2380042B (en) A cheque processor
ZA200205431B (en) A medicament.
ZA200201235B (en) A study aid.
ZA200309668B (en) A Hammermill.
ZA200203615B (en) A flag.
GB0121122D0 (en) D.a.r.t
AP2001000098S (en) Marimbira.
MXPA01005709A (es) Panel-cimbra.
MXPA01005710A (es) Losa-cimbra.
ZA200002483B (en) A wind-dryer.
GB0024022D0 (en) S.A.R.E. Energynet
AU151778S (en) A spoon
GB0112068D0 (en) Greensnail . com
AU149006S (en) A chair
AU143325S (en) A chair